Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Continuous Cell Lines and Xenografts From Pediatric Cancers for Biological and Pre-Clinical Therapeutic Studies

NCT00898755 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00898755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Continuous Cell Lines and Xenografts From Pediatric Cancers for Biological and Pre-Clinical Therapeutic Studies
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
March 5, 2007
Completion date
March 31, 2025
Enrollment
213 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, central nervous system neoplasm, ewing sarcoma, germ cell tumor, leukemia, lymphoma, malignant neoplasm, neuroblastoma, osteosarcoma, retinoblastoma, rhabdoid tumor, rhabdomyosarcoma, soft tissue sarcoma